Skip to main content
. 2009 Apr;67(4):413–420. doi: 10.1111/j.1365-2125.2009.03371.x

Table 4.

Pharmacodynamic effect on serum CTX-I

IMeal at 18.00 h IIMeal at 20.00 h IIIMeal at 21.00 h IVMeal at 22.10 h VNo meal
Mean (% h−1) −91 −130 −202 −235 −238
[95% CLM] [−135, −47] [−177, −84] [−247, −158] [−279, −190] [−282, −193]
Difference (% h−1) 147 107 35 3
[95% CI] [68, 225] [27, 187] [−43, 114] [−77, 83]
P-value 0.0003 0.008 0.58 1.00
Mean (ng ml−1 h−1) −0.40 −0.52 −1.21 −1.25 −1.47
[95% CLM] [−0.74, −0.07] [−0.87, −0.17] [−1.55, −0.88] [−1.57, −0.92] [−1.79, −1.15]
Difference (ng ml−1 h−1) 1.06 0.94 0.25 0.22
[95% CI] [0.55, 1.58] [0.42, 1.47] [−0.26, 0.77] [−0.32, 0.76]
P-value <0.0001 0.0005 0.51 0.66

Pharmacodynamic effect of salmon calcitonin (sCT) based on AUC0–4 h of serum CTX-I. The dose was given at 22.00 h. Values of AUC0–4 h of serum CTX-I are given as mean and 95% confidence interval of mean (CLM). The differences are the differences of AUC0–4 h from treatment sequences v (no meal) and the Dunnett-adjusted 95% confidence interval (CI). The P-values represent the Dunnett-adjusted significance of the multiple comparisons of the treatment sequence i, ii, iii and iv against meal treatment sequences v (no meal).